Clinical Trial Update: High-dose Intravenous Vitamin C as an Adjunctive Treatment for Sepsis in Rwanda [Phase 3]

View source ↗

Summary

Phase 3 clinical trial of high-dose intravenous vitamin C as an adjunctive treatment for sepsis was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sepsis

Drugs mentioned

• Vitamin C (ascorbic acid)

Snippet

Sponsor: Virginia Commonwealth University | Conditions: Sepsis | Phase 3 | Status: WITHDRAWN